Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2013. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding the US Retirement Savings Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific transaction notification and does not contain comprehensive financial statements.
Material Changes
A revaluation of the cash element of the notional investment held within the US Retirement Savings Plan resulted in an increase in the notional allocation of GSK American Depositary Shares (ADSs). The transaction occurred on April 12, 2013, at a price of $48.47 per ADS.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. The document strictly reports a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
Key Facts for Investor Verification
- Transaction Date: April 12, 2013.
- Notification Date: April 15, 2013.
- ADS Price: $48.47 per ADS.
- Beneficiary: Dr. K. Slaoui (Connected Person of Director Dr. M. M. Slaoui) received an increase of 1 ADS.
- Director Activity: Dr. M. M. Slaoui had no direct increase in ADSs (-).